A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)

NCT00535236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster
Herpes Zoster-related Complications

Interventions

BIOLOGICAL: V212
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC